{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:56:01Z","timestamp":1792644961017,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1038\/s41440-023-01466-w","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T09:02:46Z","timestamp":1701248566000},"page":"427-434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Gelatin\u2013PVP dissolving microneedle-mediated therapy for controlled delivery of nifedipine for rapid antihypertension treatment"],"prefix":"10.1038","volume":"47","author":[{"given":"Baishali A.","family":"Jana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Shivhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"1466_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0020-7292(95)02372-J","volume":"49","author":"EY Kwawukume","year":"1995","unstructured":"Kwawukume EY, Ghosh TS. Oral nifedipine therapy in the management of severe pre-eclampsia. Int J Gynecol Obstet. 1995;49:265\u20139.","journal-title":"Int J Gynecol Obstet"},{"key":"1466_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1034\/j.1600-0412.2002.810105.x","volume":"81","author":"A Shahnaz","year":"2002","unstructured":"Shahnaz A, Samira S. Nifedipine or hydralazine as a first-line agent to control hypertension in severe pre-eclampsia. Acta Obstet Gynecol Scand. 2002;81:25\u201330.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1466_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/0002-9378(90)91011-Z","volume":"162","author":"R John","year":"1990","unstructured":"John R, Adam K, Wayne BC. The use of nifedipine during the postpartum period in patients with severe pre-eclampsia. Am J Obstet Gynecol. 1990;162:788\u201392.","journal-title":"Am J Obstet Gynecol"},{"key":"1466_CR4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0142-9612(92)90119-9","volume":"13","author":"C Thomas","year":"1992","unstructured":"Thomas C, Chandra P. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies. Biomaterials. 1992;13:949\u201352.","journal-title":"Biomaterials"},{"key":"1466_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1248\/cpb.c13-00684","volume":"62","author":"K Ranjan","year":"2014","unstructured":"Ranjan K, Yasunori I, Yuka F, Abdul H, Shuji N, Mir I, et al. Development of highly stable nifedipine solid\u2013lipid nanoparticles. Chem Pharm Bull. 2014;62:399\u2013406.","journal-title":"Chem Pharm Bull"},{"key":"1466_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/pharmaceutics11010037","volume":"11","author":"M Athanasios","year":"2019","unstructured":"Athanasios M, Albert M. Immediate-release nifedipine binary dry powder mixtures with nanocellulose featuring enhanced solubility and dissolution rate. Pharmaceutics. 2019;11:37.","journal-title":"Pharmaceutics"},{"key":"1466_CR7","first-page":"65","volume":"1","author":"C Lal","year":"2012","unstructured":"Lal C, Garg R, Gupta G. Pharmacokinetic and pharmacodynamic studies of nifedipine loaded microspheres for the treatment of hypertension. Curr Drug Deliv. 2012;1:65\u201370.","journal-title":"Curr Drug Deliv"},{"key":"1466_CR8","first-page":"3","volume":"48","author":"C Swati","year":"2012","unstructured":"Swati C, Vinayak N, Aniruddha R, Chabukswar B, Shankar K. Solubility enhancement, physicochemical characterization and formulation of fast-dis1 solving tablet of nifedipine-beta cyclodextrin complexes. Braz J Pharm Sci. 2012;48:3\u20135.","journal-title":"Braz J Pharm Sci"},{"key":"1466_CR9","doi-asserted-by":"crossref","first-page":"30575","DOI":"10.1021\/acsami.9b09697","volume":"11","author":"X Junhua","year":"2019","unstructured":"Junhua X, Ryan D, Hongwei C, Zheng A, Meng P, Alexandra N, et al. Microneedle patch-mediated treatment of bacterial biofilms. Mater Interfaces. 2019;11:30575\u20133058.","journal-title":"Mater Interfaces"},{"key":"1466_CR10","first-page":"77","volume":"2020","author":"S Mrunmayi","year":"2020","unstructured":"Mrunmayi S, Pravin S. Engineering of nanospheres dispersed microneedle system for antihypertensive action. Curr Drug Deliv. 2020;2020:77\u201386.","journal-title":"Curr Drug Deliv"},{"key":"1466_CR11","doi-asserted-by":"publisher","first-page":"30575","DOI":"10.1021\/acsami.9b09697","volume":"11","author":"L Yan","year":"2019","unstructured":"Yan L, Fanmao L, Chen S, Bingbo Y, Di L, Hui JC, et al. Biodegradable therapeutic microneedle patch for rapid antihypertensive treatment. ACS Appl Mater Interfaces. 2019;11:30575\u201330584.","journal-title":"ACS Appl Mater Interfaces"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01466-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01466-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01466-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:07:33Z","timestamp":1707091653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01466-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1466"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01466-w","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"24 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}